NetworkNewsBreaks – Boston Scientific (BSX) Acquires Certain Neovasc (NVCN) Assets for $75M, Commits to Equity Interest
Earlier this morning, Neovasc (NASDAQ: NVCN) announced an agreement with long-term customer Boston Scientific (NYSE: BSX), pushing shares of Neovasc nearly 50% higher. Per the agreement, Boston Scientific will acquire Neovasc's tissue processing technology and facility for approximately $67.9 million in a deal expected to close by year-end 2016. Neovasc has been granted a license to the purchased assets and access to the sold facilities, which will allow the company to continue its tissue and valve assembly for its remaining customers, as well as its own tissue-related programs. Boston Scientific has also committed to purchasing 11,817,000 common shares at a…